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BACKGROUND: Well-conducted meta-analyses are considered to be at the top of the evidence-based hierarchy pyramid, with
an expansion of these publications within the cardiovascular research arena. There are limited data evaluating the trends and
quality of such publications. The objective of this study was to evaluate the methodological rigor and temporal trends of cardiovascular medicine-related meta-analyses published in the highest impact journals.
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METHODS AND RESULTS: Using the Medline database, we retrieved cardiovascular medicine-related systematic reviews and
meta-analyses published in The New England Journal of Medicine, The Lancet, Journal of the American Medical Association,
The British Medical Journal, Annals of Internal Medicine, Circulation, European Heart Journal, and Journal of American College
of Cardiology between January 1, 2012 and December 31, 2018. Among 6406 original investigations published during the study
period, meta-analyses represented 422 (6.6%) articles, with an annual decline in the proportion of published meta-analyses
(8.7% in 2012 versus 4.6% in 2018, Ptrend=0.002). A substantial number of studies failed to incorporate elements of Preferred
Reporting Items for Systematic Reviews and Meta-Analyses or Meta-Analysis of Observational Studies in Epidemiology guidelines (51.9%) and only a minority of studies (10.4%) were registered in PROSPERO (International Prospective Register of
Systematic Reviews). Fewer manuscripts failed to incorporate the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses or Meta-Analysis of Observational Studies in Epidemiology elements over time (60.2% in 2012 versus 40.0%
in 2018, Ptrend<0.001) whereas the number of meta-analyses registered at PROSPERO has increased (2.4% in 2013 versus
17.5% in 2018, Ptrend<0.001).
CONCLUSIONS: The proportion of cardiovascular medicine-related meta-analyses published in the highest impact journals has
declined over time. Although there is an increasing trend in compliance with quality-based guidelines, the overall compliance
remains low.
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W

ell-conducted and rigorous systematic reviews
and meta-analyses are considered to be the
highest level of evidence and are positioned at
the top of the evidence-based pyramid hierarchy.1 This
is accomplished by identifying and combining relevant
data to increase power, evaluating the risk of bias,
identifying sources of variation, and rating the overall

quality of existing evidence.2,3 The output of such studies carries the potential to augment existing data from
randomized controlled trials (RCTs) and observational
studies. Since their inception in the 1970s, there has
been a tremendous upsurge in the number of systematic reviews and meta-
analyses published each
year.4-6 Several factors have contributed to this trend
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CLINICAL PERSPECTIVE
What Is New?

• The number of cardiovascular medicine-related
systematic reviews and meta-
analyses published in the highest impact journals has decreased over time.
• The overall compliance with the quality standards for systematic reviews and meta-analyses
remains suboptimal.

What Are the Clinical Implications?

• Raising the awareness of these limitations and
better adherence to respective guidelines would
allow publication of only high-quality systematic
reviews and meta-analyses.

Nonstandard Abbreviations and Acronyms
MOOSE

Meta-Analysis of Observational Studies
in Epidemiology
PRISMA Preferred Reporting Items for
Systematic Reviews and Meta-Analyses
RCT
randomized controlled trial
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such as the technological advancements resulting in
the ease of access to available databases and simplified algorithm-based software to efficiently screen,
synthesize, and accurately analyze large sets of data,
as well as the rise in the production of well-conducted
RCTs and the rapid evolution of the field. This expansion in systematic reviews and meta-analyses has led
to a dramatic increase in duplication of studies with
identical subjects as well as fabrication of many disorganized, nonguideline adherent, and suboptimal-
quality studies.2,5,7 Despite this global observation,
there is a lack of objective data to study the trends in
quality, proportion, and guideline concordance of the
existing systematic reviews and meta-analyses within
the realm of cardiovascular medicine. The objectives
of this analysis were to evaluate trends of cardiovascular medicine-related systematic reviews and meta-
analyses published in highest impact journals with
regards to their methodological quality, relative proportion to original investigations, and adherence to recommended guidelines for conducting systematic reviews
and meta-analyses.

METHODS
The authors declare that all supporting data are available within the article and the online supplementary
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files. This study was exempted from institutional review
board because this is a study-level analysis.

Search Strategy and Study Selection
Criteria
Systematic reviews and meta-
analyses published in
the 8 highest Web of Science Impact Factor journals
(according to Journal Citation Reports 2018: category
“General Internal Medicine” and “Cardiology”) were included. The following journals were included: The New
England Journal of Medicine, The Lancet, Journal of
the American Medical Association, The British Medical
Journal, Annals of Internal Medicine, Circulation,
European Heart Journal, and Journal of American
College of Cardiology.8,9 The Medline database was
used to identify meta-analyses and systematic reviews
published between January 1, 2012 and December 31,
2018. Systematic reviews that did not report any quantitative data synthesis were excluded. The retrieved articles were manually screened based on the title and/
or abstract to identify cardiovascular medicine-related
publications, which were the focus of this analysis. For
each journal, we also identified the number of original
investigation publications over the same period. Three
investigators (D.M., A.T., and A.S.) worked independently to extract the data. In case of discrepancies,
the full text was reviewed by an independent investigator (I.E.) along with the previous author to reach a
consensus.

Data Extraction and Assessment of
Methodological Quality
For each cardiovascular medicine-related article, we
identified the following variables: year of publication,
registration in PROSPERO (International Prospective
Register of Systematic Reviews), change in the study
protocol, type of meta-
a nalysis (pairwise versus
network), type of studies included (RCTs, observational trials, or both), data level (patient level versus
study level), focus of the article, funding source (industry versus nonindustry), and access (open versus closed access). Furthermore, full-length articles
were reviewed to assess the methodological quality
of the systematic reviews and meta-a nalyses based
on the Preferred Reporting Items for Systematic
Reviews and Meta-A nalyses (PRISMA) and Meta-
Analysis of Observational Studies in Epidemiology
(MOOSE) guidelines (Table S1).10,11 The quality of
systematic reviews and meta-a nalyses was judged
on the following factors: mention of “meta-a nalysis
or systematic review” in the title, inclusion of a
PRISMA flow diagram, assessment of risk bias,
use of Grading of Recommendations Assessment,
Development and Evaluation (GRADE) assessment,
assessment of publication bias if >10 studies, and
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assessment of heterogeneity as well as exploration
via subgroup, sensitivity, or metaregression analyses if the degree of statistical heterogeneity was
high. Heterogeneity was defined as being high if
I2 statistic was >50%.12 The overall assessment of
these variables for each included meta-a nalysis is
reported in Table S2.

Statistical Analysis
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We assessed the proportion of cardiovascular
medicine-
related systematic reviews and meta-
analyses in relation to the overall number of original
investigations published in the same journal during the same publication year. After stratifying the
publications by the year of publication, we computed the percentage of systematic reviews and
meta-a nalyses published as compared with original
investigations. Subsequently, we assessed the temporal trend in the ratio of published cardiovascular
medicine-
related systematic reviews and meta-
analyses to original investigations. The distribution
of the aforementioned variables was evaluated for
all cardiovascular medicine-related systematic reviews and meta-a nalyses. Chi-s quare test for linear
trend was used to evaluate current temporal trends.
The rates were expressed as a percentage and all
P values were double sided. All categorical variables were reported as raw frequencies and overall
percentages. All 2-s ided P values were considered
significant at the α=0.05 level. We used SAS version 9.1.3 (SAS Institute, Inc., Cary, NC) and Stata
version 14 (StataCorp, College Station, TX) for all
analyses.

Quality of Cardiovascular-Related Meta-Analyses

Table 1. Overall Characteristics of Cardiovascular
Medicine−Related Systematic Reviews and Meta-Analyses
Cardiovascular medicine−related systematic
reviews and meta-analyses

Studies
(n=422)

Journal, n (%)
The New England Journal of Medicine

1 (0.2)

The Lancet

43 (10.2)

Journal of American Medical Association

20 (4.7)

British Medical Journal

71 (16.8)

Annals of Internal Medicine

44 (10.4)

Circulation

72 (17.1)

European Heart Journal

76 (18.0)

Journal of American College of Cardiology

95 (22.5)

Type of meta-analysis, n (%)
Pairwise

387 (91.7)

Network

35 (8.3)

Type of studies included, n (%)
Randomized controlled trials

215 (50.9)

Observational studies

120 (28.4)

Both

87 (20.6)

Level of meta-analysis, n (%)
Patient level

70 (16.6)

Study level

352 (83.4)

Focus of study, n (%)
Therapeutic

239 (56.6)

Epidemiology

89 (21.1)

Diagnostics

60 (14.2)

Other

49 (11.6)

Source of funding, n (%)
None

144 (34.1)

Industry

65 (15.4)

Nonindustry

213 (50.5)

Open access publication, n (%)

237 (56.2)

RESULTS
Included Meta-Analyses
The search identified 6406 original investigations published during the study period in the journals reviewed,
with meta-analyses representing 422 (6.6%) articles.
The ratio of original investigations to systematic reviews
and meta-analyses ratio was ≈14:1. The characteristics
of the systematic reviews and meta-analyses are displayed in Table 1. Notably, a large proportion of studies were pairwise meta-analyses (91.7%), exclusively
included RCTs (50.9%), and were nonindustry funded
(50.5%). Patient-
level meta-
analyses comprised only
a small proportion (16.6%) of all systemic reviews and
meta-analyses.

Temporal Trends
During the study period, there was a decreasing
trend in the number of published systematic reviews and meta-analyses (68 studies in 2012 versus

40 studies in 2018, P trend=0.006). Furthermore, we
observed a decreasing trend in the proportion of
cardiovascular medicine-related systematic reviews
and meta-analyses to original investigations (8.7% in
2012 versus 4.6% in 2018, P trend=0.002) (Figure 1).
There was a decline in the proportion of systematic
reviews and meta-analyses that did not follow the elements of PRISMA or MOOSE guidelines (60.2% in
2012 versus 40.0% in 2018, P trend<0.001) (Figure 2).
The proportion of studies registered in PROSPERO
demonstrated an increasing trend over time (2.4% in
2013 [PROSPERO was launched in late 2011] versus
17.5% in 2018, P trend<0.001) (Figure 3). Finally, there
were no significant temporal change in the number
of industry-
funded studies (P trend=0.16), systematic
reviews and meta-analyses consisting of only RCTs
(P trend=0.92), and number of patient-
level meta-
analyses (P trend=0.43).
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Figure 1. Temporal trend in proportion of published systematic reviews and meta-analyses and their methodological rigor.
A, Proportion of cardiovascular related systematic reviews and meta-analyses to original investigations were calculated and stratified
by the year of publication. Trend analysis was conducted to depict P-trend. B, Frequency of methodological rigor was calculated
based on compliance with various elements of PRISMA and MOOSE guidelines as well as PROSPERO registration. GRADE indicates
Grading of Recommendations Assessment, Development and Evaluation; MOOSE, Meta-Analysis of Observational Studies in
Epidemiology; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; and PROSPERO, International
Prospective Register of Systematic Reviews.

Assessment of Meta-Analyses Quality
Table 2 demonstrates the compliance of studies with
guidelines for conducting high-quality systematic reviews and meta-
analyses. A substantial proportion
(51.9%) of all systematic reviews and meta-analyses
failed to incorporate MOOSE or PRISMA guidelines.
The majority of systematic reviews and meta-analyses
published did not include all PRISMA elements: flow
diagram (66.6%), risk assessment of bias (53.1%), assessment of heterogeneity (83.4%), exploration via subgroup analyses or sensitivity analyses in cases of high
heterogeneity (78.7%), and assessment of publication
bias (54.3%). Registration in PROSPERO (10.4%) and
use of GRADE assessment (7.1%) was incorporated by

a small proportion of all systematic reviews and meta-
analyses (Figure 1).

DISCUSSION
In this comprehensive analysis of cardiovascular
medicine-
related systematic reviews and meta-
analyses, we demonstrated that approximately 1 in
14 original investigations published in the 8 highest
impact journals between 2012 and 2018 were meta-
analyses. In addition, the proportion of systematic
reviews and meta-analyses to original investigations
has significantly decreased over time in these journals. Although there has been a significant rise in the
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Figure 2. Temporal trend among systematic reviews and meta-
analyses failing to
comply with PRISMA or MOOSE guideline elements.
Proportion of studies that did not incorporate PRISMA or MOOSE guideline elements were
calculated and stratified by the year of publication. Trend analysis was conducted to depict
P-
trend. MOOSE indicates Meta-
Analysis of Observational Studies in Epidemiology; and
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
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proportion of systematic reviews and meta-analyses
registered in PROSPERO, the overall percentage of
systematic reviews and meta-
analyses registered
in PROSPERO remains small (~10%). Similarly, although we observed an increasing temporal trend
in the incorporation of elements from PRISMA or
MOOSE guidelines, a greater proportion of cardiovascular systematic reviews and meta-analyses did
not comply with all domains of PRISMA or MOOSE
guidelines.
In light of recent technological advancements
including ease of access to large publicly accessible databases and software with capabilities to
screen and analyze prior publications,13 together
with the rapidly expanding base of RCTs, there has
been a high level of interest in generating systematic reviews and meta-
analyses by various investigator groups. Accordingly, the clinical research
community has criticized and voiced mixed feelings
toward the quality of this burgeoning expansion of
systematic reviews and meta-analyses.2,3,5,7 In this
analysis, which focused only on the highest impact
journals as defined by impact factor, we observed
a decreasing trend in published systematic reviews
and meta-analyses. This trend observed is in stark
contrast to the previously reported uptrend in other
specialties.4,14 This might be attributed to several
factors. Editors and reviewers of these highest impact journals may curtail the number of systematic
reviews and meta-
analyses that successfully pass
the peer-review process. Moreover, evidence-based

medicine in the cardiovascular community has been
primarily driven by large RCTs and high-quality observational studies. The fact that systematic reviews
and meta-
analyses mostly confirm the findings of
these high-quality original investigations by providing
more refined estimates to the effect size may prohibit
their uptake in these high-impact journals. Finally, a
potential redundancy in data and suboptimal compliance with quality standards may predispose the
authors of non-high-quality systematic reviews and
meta-analyses to avoid submission to these high-
impact journals.15,16
This study demonstrated that a significant proportion
of cardiovascular medicine-
related systematic reviews
and meta-analyses published in high-impact journals did
not adequately fulfill guideline recommended elements
of publishing high-quality systematic reviews and meta-
analyses (ie, PRISMA or MOOSE guidelines). Compliance
with elements such as the use of GRADE assessment,
incorporation of a flow diagram, and assessment of risk
bias and publication bias remained particularly low. Our
findings, which highlight the suboptimal compliance with
PRISMA and MOOSE guidelines, are in line with what
has been previously demonstrated in other clinical areas
of research.17-20 These investigations have reported a
compliance rate of as low as 50% with PRISMA and
MOOSE guidelines among systematic reviews and meta-
analyses, a finding that is consistent with our results despite the high-impact nature of our selected journals. We
also observed that only a minority of the included meta-
analyses reported the GRADE assessment. The steady
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Figure 3. Temporal trend in the proportion of published cardiovascular medicine-related systematic reviews and meta-
analyses with PROSPERO registration.
Proportion of studies with PROSPERO registration were calculated and stratified by the year of publication. PROSPERO indicates
International Prospective Register of Systematic Reviews.
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dissemination of these quality standards and guidelines
can be attributed to the increasing temporal trend in the
incorporation of these guideline elements as demonstrated in our analysis.21,22 However, the continued suboptimal rates of compliance may be in part attributed to
the lack of adoption of such guidelines by investigator
groups. Additionally, lack of awareness by investigator
groups and relying on methodology noted in prior high-
impact journal publications rather than seeking out specific PRISMA and MOOSE guideline checklists may also
propagate the manufacturing of suboptimal quality systematic reviews and meta-analyses.
An overall increase in the temporal trend of
PROSPERO registration was also demonstrated by
our analyses. Launched in 2011, the primary aim of
PROSPERO is to provide transparency about ongoing systematic reviews.23,24 Registration in PROSPERO
serves to avoid unnecessary duplication of similar analyses, minimize reporting bias, and hold authors accountable for reporting all prespecified end
points.25,26 Therefore, registration in PROSPERO
protects systematic reviews against biases that may
otherwise dilute and discredit the reported results.
A large-scale analysis by Page et al demonstrated a
significant increase in registration of systematic reviews in PROSPERO between 2011 and 2017.27 The
authors demonstrated a roughly 10-
fold increase in
PROSPERO registration. Our results pertaining to

cardiovascular medicine-
related systematic reviews
are in line with such observations. Despite this, it is
noteworthy that among the overall published systematic reviews and meta-
analyses, only 1 in 10 were
registered in PROSPERO. Hence, although there
has been an uptrend over time, the compliance with
PROSPERO registration remains poor. Future investigations evaluating barriers to PROSPERO registration
are needed to fully understand the reasons behind
our findings. Identifying such obstacles would help
improve PROSPERO registration rates and thereby
provide credible and high-quality systematic reviews to
the research community.
This study has some limitations that are worth
noting. First, additional information regarding overlap
among systematic reviews and meta-analyses topics
could not be ascertained in our study, but other studies have shown that there are concerns related to overlapping cardiovascular-related meta-analyses.7,15 We
were unable to assess whether authorship guidelines
of the included journals have evolved over time with
regard to requiring adherence to qualitative guidelines
and whether this has contributed to the observed trend
in adherence to MOOSE and PRISMA guidelines. The
results noted in our study may not be representative
of noncardiovascular-related systematic reviews and
meta-analyses or generalizable to lower impact cardiovascular journals. Finally, we did not have to access
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Table 2. Compliance with Guidelines for Conducting High-Quality Systematic Reviews and Meta-Analyses
Guidelines-based quality
metrics

Relevance and definition

Compliant studies, n (%)

PROSPERO (International Prospective Register of Systematic Reviews)
Registration

PROSPERO is an international database of prospectively registered systematic reviews
in health care. A permanent record of essential details of study protocol is maintained.
Studies should be registered in PROSPERO at the protocol/inception stage and details
should be entered to avoid unplanned duplication and to enable comparison between
published methods and planned protocol. A lack of registration in PROSPERO may
discredit a study because of the potential of subject duplication or modification of
methods during data analysis stage.

44 (10.4%)

Change in PROSPERO
protocol

A change in PROSPERO protocol refers to divergence from predefined methods
or assessment of variables. A change in PROSPERO protocol without reasonable
explanation may discredit a study.

3 (6.8%)

Preferred Reporting Items for Systematic Reviews and Meta-Analyses elements

Downloaded from http://ahajournals.org by on February 24, 2022

Title indicates “Meta-
analysis” or “Systematic
Review”

Title should clearly identify the study as a systematic review, meta-analysis, or both.
Without proper identification and transparency, the study may be perceived as an
original investigation by the readership on a quick glance. A lack of proper title may
result in misperceptions regarding the robustness of conclusions disseminated by the
study.

343 (81.3)

Flow diagram provided

A flow diagram should be provided with clear identification of methods used to acquire
the study sample, procedure for screening studies, assessment of study eligibility,
and the number of studies included in the analysis. The number of studies excluded
and the reasons for exclusions should also be highlighted at each stage. Without such
transparency displayed in a flow diagram, a systematic review or meta-analysis may
lose credibility in their methodology of cohort creation.

281 (66.6)

Risk of bias assessed

The risk of bias should be assessed in individual studies and across all the included
studies. The investigators should specify assessment of such risk, whether this was
performed at the study level or outcome level, and how it should be incorporated during
data-interpretation of the cumulative evidence. Without a thorough assessment of risk
bias, the results reported by cumulative systematic review or meta-analysis may lose
credibility.

224 (53.1)

Use of GRADE assessment

GRADE assessment developed by the Grading of Recommendation, Assessment,
Development and Evaluation (GRADE) working group aims to grade quality of evidence
and strength of recommendation presented by healthcare outcomes. This approach
allows for a consistent method of assessing the quality of evidence for predefined
outcomes across several studies. The quality of evidence is rated as high, moderate,
low, or very low. All inclusive, this allows for a transparent judgment of the quality of
evidence provided by the studies included in the systematic review or meta-analyses.
Without GRADE assessment, the quality of evidence included in the systematic review
or meta-analysis remains questionable and thereby decreasing the robustness of the
conclusions drawn.

30 (7.1)

Assessment of
heterogeneity

Heterogeneity refers to the variation in evaluated outcomes among the included studies.
I2 statistic is often used to assess variation across studies with higher I2 indicative of
higher variance in results that is attributable to heterogeneity in the studies included.
Without assessment of heterogeneity, the estimation of the combined effect of studies
included in the meta-analysis or systematic review is often discredited.

352 (83.4)

Exploration via subgroup
analysis, sensitivity analysis,
or meta-regression (if
heterogeneity was high)

If heterogeneity across the studies included is high, further exploratory analyses (such
as subgroup analysis, sensitivity analysis, or metaregression) must be performed to
validate the results displayed by the systematic review or meta-analysis. Without a
well-conducted exploratory analysis in the setting of high heterogeneity, the conclusions
drawn by the study may not be validated.

277 (78.7)*

Assessment of publication
bias (if >10 studies)

Publication bias refers to the higher likelihood of a study being published based on
not only the quality of methodology, but also the hypothesis tested, significance,
and directionality of results presented. This may result in studies supporting their
hypothesis being published more often and faster as compared with studies refuting
their hypothesis. Without evaluation of publication bias, the conclusions drawn by the
systematic review or meta-analysis ought to be interpreted with caution.

216 (54.3)†

*277/352 (No of studies with further exploration in cases of high heterogeneity / # of studies with assessment of heterogeneity).
†
216/398 (No of studies with assessment of publication bias / # of studies with analysis of >10 studies).

to the submission rates of meta-analyses among the
included journals, which might contribute to the reduction in the number of published meta-analyses among
the included journals.

CONCLUSIONS
The number of cardiovascular medicine-related systematic reviews and meta-analyses published in the
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highest impact journals has decreased over time. The
proportion of these systematic reviews and meta-
analyses to original articles published in such journals has also experienced a downtrend. The overall
compliance with the quality standards for systematic reviews and meta-analyses remains suboptimal.
Similarly, although PROSPERO registration for systematic reviews has increased over time, only 1 in 10
cardiovascular medicine-
related systematic reviews
are registered in PROSPERO. High-quality systematic reviews and meta-analyses serve as an important constituent of the wide range of methodological
studies. Raising the awareness of these limitations
and better adherence to respective guidelines would
allow publication of only high-quality systematic reviews and meta-analyses.
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Table S1. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Checklist.
Reporting of background should include:
- Problem definition
- Hypothesis statement
- Description of study outcome(s)
- Type of exposure or intervention used
- Type of study designs used
- Study population
Reporting of search strategy should include:
- Qualifications of searchers
- Search strategy, including time period included in the synthesis and keywords
- Effort to include all available studies, including contact with authors
- Databases and registries searched
- Search software used, name and version, including special features used
- Use of hand searching
- List of citations located and those excluded, including justification
- Method of addressing article published in languages other than English
- Method of handling abstracts and unpublished studies
- Description of any contact with authors
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Reporting of methods should include:
- Description of relevance or appropriateness of studies assembled for assessing the
hypothesis to be tested
- Rationale for the selection and coding of data
- Documentation of how data were classified and coded
- Assessment of confounding
- Assessment of study quality, including blinding of quality assessors, stratification or
regression on possible predictors of study results
- Assessment of heterogeneity
- Description of statistical methods in sufficient details to be replicated
- Provision of appropriate tables and graphics
Reporting of results should include:
- Graphic summarizing individual study estimates and overall estimate
- Table giving descriptive information for each study included
- Results of sensitivity testing
- Indication of statistical uncertainty of findings
Reporting of discussion should include:
- Quantitative assessment of bias
- Justification for exclusion
- Assessment of quality of included studies

Reporting of conclusions should include:
- Consideration of alternative explanations of observed results
- Generalization of the conclusions
- Guidelines for future research
- Disclosure of funding source
Table adapted from Stroup et al. JAMA 2000;283:2008-12.
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Table S2. Individual assessment for each meta-analysis (see Excel file).
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